Goldman Sachs Group Inc Tenaya Therapeutics, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 306,008 shares of TNYA stock, worth $367,209. This represents 0.0% of its overall portfolio holdings.
Number of Shares
306,008
Previous 315,802
3.1%
Holding current value
$367,209
Previous $609,000
28.24%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding TNYA
# of Institutions
86Shares Held
43.7MCall Options Held
74.3KPut Options Held
192K-
Column Group LLC San Francisco, CA9.4MShares$11.3 Million24.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$8.08 Million0.83% of portfolio
-
Jpmorgan Chase & CO New York, NY5.16MShares$6.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$4.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$3.93 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $49.6M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...